<DOC>
	<DOCNO>NCT02316119</DOCNO>
	<brief_summary>Background : About 5 % patient acute coronary syndrome ( ACS ) previously ischemic stroke ( IS ) transitory ischemic attack ( TIA ) . This high-risk population , high incidence ischemic event , also bleed event . While high ischemic risk population attribute high prevalence cardiovascular risk factor , predisposition bleed event well understood . Hypothesis : The increase bleeding risk ACS patient history cerebrovascular event may justify low platelet activity . Methods : Unicentric , prospective , case-control study , include approximately 100 post-ACS patient history IS/TIA previously acute coronary event ( Case Group ) 100 patient without IS/TIA ( Control group ) . The group match gender , age , ACS type year occurrence . All patient take aspirin , main exclusion criterion use dual antiplatelet therapy , previous hemorrhagic stroke , severe renal dysfunction , thrombocytopenia coagulopathy . Main analysis : Platelet aggregation evaluate 6 method : VerifyNow Aspirin速 , VerifyNow P2Y12速 , PFA 100速 , thrombelastography ( ReoRox速 ) , light transmission aggregometry ADP ( LTA ADP ) epinephrine ( LTA EPI ) agonists . Additional analysis : genetic , HDL transport inflammatory evaliation</brief_summary>
	<brief_title>Mechanistic Study Bleeding Risk Coronary Patients With Cerebrovascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<criteria>PostACS patient history IS/TIA previously acute coronary event take aspirin Sign consent form Hemorrhagic stroke Another antiplatelet drug aspirin Use Anti inflammatory drug Severe chronic kidney dysfunction Liver disease Coagulopathy Platelet disfunction Thrombocytopenia thrombocytosis Refuse sign consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>bleed risk , acute coronary syndrome , platelet agregation ,</keyword>
</DOC>